New personalized therapy improves survival for patients with CLL leukemia, phase 3 trial finds

by

Personalized treatment for the most common form of adult leukemia helps patients survive for longer and stay in remission, a phase 3 trial has found.

Leave A Comment

Your email address will not be published. Required fields are marked *